Robust Quarterly Result Lifted LeMaitre Vascular (LMAT) in Q2

Robust Quarterly Result Lifted LeMaitre Vascular (LMAT) in Q2

Conestoga Capital Advisors' Q2 2024 investor letter discusses the market moderation, with small-cap stocks underperforming. They highlighted LeMaitre Vascular, Inc. as a notable stock pick, showing growth potential. They emphasize AI stocks for higher returns in a shorter timeframe.

Read More

Did you find this insightful?